ScreenPro FH
Screening Project for Familial Hypercholesterolemia
in Central, Southern and Eastern Europe

New article “FH and COVID-19: triggering of increased sustained CV risk”

Approximately 30 million people worldwide suffer from familial hypercholesterolaemia. These patients have an increased risk of atherosclerotic cardiovascular disease and its atherothrombotic complications already in middle age. It is likely that COVID-19 further increases their cardiovascular risk, both during infection and after recovery. We advise continued use of treatment for the severe hypercholesterolaemia observed in these patients.  

Please find the article HERE.